Cargando…
Direct quantification of in vivo mutagenesis and carcinogenesis using duplex sequencing
The ability to accurately measure mutations is critical for basic research and identifying potential drug and chemical carcinogens. Current methods for in vivo quantification of mutagenesis are limited because they rely on transgenic rodent systems that are low-throughput, expensive, prolonged, and...
Autores principales: | Valentine, Charles C., Young, Robert R., Fielden, Mark R., Kulkarni, Rohan, Williams, Lindsey N., Li, Tan, Minocherhomji, Sheroy, Salk, Jesse J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776782/ https://www.ncbi.nlm.nih.gov/pubmed/33318186 http://dx.doi.org/10.1073/pnas.2013724117 |
Ejemplares similares
-
Genetic toxicity testing using human in vitro organotypic airway cultures: Assessing DNA damage with the CometChip and mutagenesis by Duplex Sequencing
por: Wang, Yiying, et al.
Publicado: (2021) -
Epigenetic Regulatory Mechanisms Associated with Infertility
por: Minocherhomji, Sheroy, et al.
Publicado: (2010) -
Duplex sequencing identifies genomic features that determine susceptibility to benzo(a)pyrene-induced in vivo mutations
por: LeBlanc, Danielle P. M., et al.
Publicado: (2022) -
The in vivo role of Rev1 in mutagenesis and carcinogenesis
por: Sasatani, Megumi, et al.
Publicado: (2020) -
Next‐Generation Genotoxicology: Using Modern Sequencing Technologies to Assess Somatic Mutagenesis and Cancer Risk
por: Salk, Jesse J., et al.
Publicado: (2019)